Hong Kong medical journal = Xianggang yi xue za zhiHumansCarcinomaHepatocellularSorafenibLiver Neoplasms
Specific indicators of unsuitability for transarterial chemoembolisation in patients with intermediate-stage hepatocellular carcinoma according to thresholds of tumour burden and liver function as judged by survival benefit over sorafenib.
L M Chen, S C H Yu, L Li, E P Hui, W Yeo, S L Chan
Published: 202510.12809/hkmj2311239
Abstract
INTRODUCTION: This study aimed to define specific indicators of unsuitability for transarterial chemoembolisation (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC) in Hong Kong using thresholds of tumour burden and liver funct…
Preview only. Read the full abstract at the source